Matrix-induced autologous chondrocyte implantation (MACI) is an established technique for the repair of knee chondral defects. While a number of factors may affect the clinical outcome, little is known about the influence of subchondral bone abnormalities at the time of surgery on pain and graft outcomes after MACI.
Purpose:
To investigate the association between subchondral bone marrow edema within 3 months before MACI surgery on preoperative and postoperative reported pain and symptoms as well as postoperative graft outcomes.
Study Design:
Cohort study; Level of evidence, 3.
Methods:
This retrospective study was undertaken in 56 patients undergoing MACI with clinical and radiological assessments before surgery and at 3, 12, 24, and 60 months after surgery. Patients were assessed using the Pain and Symptoms subscales of the Knee Injury and Osteoarthritis Outcome Score (KOOS). High-resolution magnetic resonance imaging (MRI) was used to evaluate the severity of preoperative subchondral bone marrow edema, while graft infill and an MRI composite graft score were evaluated after surgery via the magnetic resonance observation of cartilage repair tissue (MOCART) scoring system. Linear regression utilizing generalized estimating equations was used to investigate the association between preoperative subchondral bone marrow edema scores and preoperative and postoperative KOOS subscores as well as postoperative MRI-based scores of graft repair.
Results:
The degree of preoperative subchondral bone marrow edema was not significantly associated with postoperative outcomes, whereby there was no evidence of a difference between edema subgroups over all time points for the KOOS-Pain subscore (P = .644), KOOS-Symptoms subscore (P = .475), or MRI composite score (P = .685) after adjustment for potential confounders of age, body mass index, defect size, and defect location.
Conclusion:
No association was demonstrated between the severity of preoperative subchondral bone marrow edema with postoperative patient-reported knee pain or symptoms or postoperative graft repair assessed via MRI.
AignerNPetjeGSteinboeckGSchneiderWKrasnyCLandsiedlF. Treatment of bone-marrow oedema of the talus with the prostacyclin analogue iloprost: an MRI-controlled investigation of a new method. J Bone Joint Surg Br. 2001;83(6):855-858.
2.
BasadEIshaqueBBachmannGSturzHSteinmeyerJ. Matrix-induced autologous chondrocyte implantation versus microfracture in the treatment of cartilage defects of the knee: a 2-year randomised study. Knee Surg Sports Traumatol Arthrosc. 2010;18(4):519-527.
3.
BauerSKhanRJEbertJR. Knee joint preservation with combined neutralising high tibial osteotomy (HTO) and matrix-induced autologous chondrocyte implantation (MACI) in younger patients with medial knee osteoarthritis: a case series with prospective clinical and MRI follow-up over 5 years. Knee. 2012;19(4):431-439.
BeiserIHKanatIO. Subchondral bone drilling: a treatment for cartilage defects. J Foot Surg. 1990;29(6):595-601.
6.
BekkersJEde WindtTSRaijmakersNJDhertWJSarisDB. Validation of the Knee Injury and Osteoarthritis Outcome Score (KOOS) for the treatment of focal cartilage lesions. Osteoarthritis Cartilage. 2009;17(11):1434-1439.
7.
BrittbergMLindahlANilssonAOhlssonCIsakssonOPetersonL. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med. 1994;331(14):889-895.
8.
BrittbergMWinalskiCS. Evaluation of cartilage injuries and repair. J Bone Joint Surg Am. 2003;85(Suppl 2):58-69.
9.
CarboneLDNevittMCWildyK. The relationship of antiresorptive drug use to structural findings and symptoms of knee osteoarthritis. Arthritis Rheum. 2004;50(11):3516-3525.
10.
de WindtTSBekkersJECreemersLBDhertWJSarisDB. Patient profiling in cartilage regeneration: prognostic factors determining success of treatment for cartilage defects. Am J Sports Med. 2009;37(Suppl 1):58S-62S.
11.
DomayerSEWelschGHDorotkaR. MRI monitoring of cartilage repair in the knee: a review. Semin Musculoskelet Radiol. 2008;12(4):302-317.
EbertJRFallonMRobertsonWB. Radiological assessment of accelerated versus traditional approaches to post-operative rehabilitation following matrix-induced autologous chondrocyte implantation (MACI). Cartilage. 2011;2(1):60-72.
14.
EbertJRFallonMZhengMHWoodDJAcklandTR. A randomized trial comparing accelerated and traditional approaches to postoperative weightbearing rehabilitation after matrix-induced autologous chondrocyte implantation: findings at 5 years. Am J Sports Med. 2012;40(7):1527-1537.
15.
EbertJRRobertsonWBWoodhouseJ. Clinical and magnetic resonance imaging-based outcomes to 5 years after matrix-induced autologous chondrocyte implantation to address articular cartilage defects in the knee. Am J Sports Med. 2011;39(4):753-763.
16.
EbertJRSmithAEdwardsPKHamblyKWoodDJAcklandTR. Factors predictive of outcome 5 years after matrix-induced autologous chondrocyte implantation in the tibiofemoral joint. Am J Sports Med. 2013;41(6):1245-1254.
17.
FelsonDT. The sources of pain in knee osteoarthritis. Curr Opin Rheumatol. 2005;17(5):624-628.
18.
FilardoGKonEDi MartinoA. Is the clinical outcome after cartilage treatment affected by subchondral bone edema?Knee Surg Sports Traumatol Arthrosc. 2014;22(6):1337-1344.
19.
GenoveseERongaMAngerettiMG. Matrix-induced autologous chondrocyte implantation of the knee: mid-term and long-term follow-up by MR arthrography. Skeletal Radiol. 2010;40:47-56.
20.
ImhofHSulzbacherIGramppSCzernyCYoussefzadehSKainbergerF. Subchondral bone and cartilage disease: a rediscovered functional unit. Invest Radiol. 2000;35(10):581-588.
21.
JaiswalPKBentleyGCarringtonRWSkinnerJABriggsTW. The adverse effect of elevated body mass index on outcome after autologous chondrocyte implantation. J Bone Joint Surg Br. 2012;94(10):1377-1381.
22.
KawamuraSWakitaniSKimuraT. Articular cartilage repair: rabbit experiments with a collagen gel-biomatrix and chondrocytes cultured in it. Acta Orthop Scand. 1998;69(1):56-62.
23.
KijowskiRStantonPFineJDe SmetA. Subchondral bone marrow edema in patients with degeneration of the articular cartilage of the knee joint. Radiology. 2006;238(3):943-949.
24.
KnutsenGDrogsetJOEngebretsenL. A randomized trial comparing autologous chondrocyte implantation with microfracture: findings at five years. J Bone Joint Surg Am. 2007;89(10):2105-2112.
25.
KreuzPCMullerSFreymannU. Repair of focal cartilage defects with scaffold-assisted autologous chondrocyte grafts: clinical and biomechanical results 48 months after transplantation. Am J Sports Med. 2011;39(8):1697-1705.
26.
KrishnanSPSkinnerJABartlettW. Who is the ideal candidate for autologous chondrocyte implantation?J Bone Joint Surg Br. 2006;88(1):61-64.
27.
KurkijarviJENissiMJKivirantaIJurvelinJSNieminenMT. Delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) and T2 characteristics of human knee articular cartilage: topographical variation and relationships to mechanical properties. Magn Reson Med. 2004;52(1):41-46.
28.
LahmAKreuzPCEl-TayehA. Loss of zonal organization of articular cartilage after experimental subchondral trauma of the knee joint. Saudi Med J. 2007;28(4):649-652.
29.
MarlovitsSSingerPZellerPMandlIHallerJTrattnigS. Magnetic resonance observation of cartilage repair tissue (MOCART) for the evaluation of autologous chondrocyte transplantation: determination of interobserver variability and correlation to clinical outcome after 2 years. Eur J Radiol. 2006;57(1):16-23.
30.
MarlovitsSStriessnigGResingerCT. Definition of pertinent parameters for the evaluation of articular cartilage repair tissue with high-resolution magnetic resonance imaging. Eur J Radiol. 2004;52(3):310-319.
31.
NiemeyerPSalzmannGSteinwachsM. Presence of subchondral bone marrow edema at the time of treatment represents a negative prognostic factor for early outcome after autologous chondrocyte implantation. Arch Orthop Trauma Surg. 2010;130(8):977-983.
32.
NiemeyerPSteinwachsMErggeletC. Autologous chondrocyte implantation for the treatment of retropatellar cartilage defects: clinical results referred to defect localisation. Arch Orthop Trauma Surg. 2008;128(11):1223-1231.
33.
OssendorfCKapsCKreuzPCBurmesterGRSittingerMErggeletC. Treatment of posttraumatic and focal osteoarthritic cartilage defects of the knee with autologous polymer-based three-dimensional chondrocyte grafts: 2-year clinical results. Arthritis Res Ther. 2007;9(2):R41.
34.
PetersonLMinasTBrittbergMNilssonASjogren-JanssonELindahlA. Two- to 9-year outcome after autologous chondrocyte transplantation of the knee. Clin Orthop Relat Res. 2000;374:212-234.
35.
PetersonLVasiliadisHSBrittbergMLindahlA. Autologous chondrocyte implantation: a long-term follow-up. Am J Sports Med. 2010;38(6):1117-1124.
36.
PietschmannMFHorngANiethammerT. Cell quality affects clinical outcome after MACI procedure for cartilage injury of the knee. Knee Surg Sports Traumatol Arthrosc. 2009;17(11):1305-1311.
37.
RobertsonWBFickDWoodDJLinklaterJMZhengMHAcklandTR. MRI and clinical evaluation of collagen-covered autologous chondrocyte implantation (CACI) at two years. Knee. 2007;14(2):117-127.
38.
RoosEEngelhartLRanstamJ. ICRS recommendation document: patient-reported outcome instruments for use in patients with articular cartilage defects. Cartilage. 2011;2(2):122-136.
39.
RoosEMRoosHPLohmanderLSEkdahlCBeynnonBD. Knee Injury and Osteoarthritis Outcome Score (KOOS): development of a self-administered outcome measure. J Orthop Sports Phys Ther. 1998;28(2):88-96.
40.
RubinDAHarnerCDCostelloJM. Treatable chondral injuries in the knee: frequency of associated focal subchondral edema. AJR Am J Roentgenol. 2000;174(4):1099-1106.
41.
SarisDBVanlauweJVictorJ. Treatment of symptomatic cartilage defects of the knee: characterized chondrocyte implantation results in better clinical outcome at 36 months in a randomized trial compared to microfracture. Am J Sports Med. 2009;37(Suppl 1):10S-19S.
42.
TakahashiTTinsBMcCallIWRichardsonJBTakagiKAshtonK. MR appearance of autologous chondrocyte implantation in the knee: correlation with the knee features and clinical outcome. Skeletal Radiol. 2006;35(1):16-26.
43.
TideriusCJTjornstrandJAkesonPSoderstenKDahlbergLLeanderP. Delayed gadolinium-enhanced MRI of cartilage (dGEMRIC): intra- and interobserver variability in standardized drawing of regions of interest. Acta Radiol. 2004;45(6):628-634.
44.
TrattnigSMillingtonSASzomolanyiPMarlovitsS. MR imaging of osteochondral grafts and autologous chondrocyte implantation. Eur Radiol. 2007;17(1):103-118.
45.
TrattnigSPinkerKKrestanCPlankCMillingtonSMarlovitsS. Matrix-based autologous chondrocyte implantation for cartilage repair with Hyalograft((R))C: two-year follow-up by magnetic resonance imaging. Eur J Radiol. 2006;57(1):9-15.
46.
VasiliadisHSWasiakJ. Autologous chondrocyte implantation for full thickness articular cartilage defects of the knee. Cochrane Database Syst Rev. 2010;(10):CD003323.
47.
WelschGHMamischTCZakL. Evaluation of cartilage repair tissue after matrix-associated autologous chondrocyte transplantation using a hyaluronic-based or a collagen-based scaffold with morphological MOCART scoring and biochemical T2 mapping: preliminary results. Am J Sports Med. 2010;38(5):934-942.
48.
WondraschBZakLWelschGHMarlovitsS. Effect of accelerated weightbearing after matrix-associated autologous chondrocyte implantation on the femoral condyle on radiographic and clinical outcome after 2 years: a prospective, randomized controlled pilot study. Am J Sports Med. 2009;37(Suppl 1):88S-96S.
49.
ZaslavKColeBBrewsterR. A prospective study of autologous chondrocyte implantation in patients with failed prior treatment for articular cartilage defect of the knee: results of the Study of the Treatment of Articular Repair (STAR) clinical trial. Am J Sports Med. 2009;37(1):42-55.
